Abstract
The LH receptor (LHR) and FSH receptor (FSHR), collectively termed the gonadotropin receptors, are members of the Family A of GPCRs. The gonadotropin receptors each contain N-linked carbohydrates that are not directly involved in hormone binding, but contribute to the proper folding, and therefore, cell surface expression of the receptor. Loss-of-function mutations of an LHR or FSHR results in decreased target cell responsiveness. Most inactivating mutations cause receptor misfolding, resulting in the retention of the mutant in its immature form in the endoplasmic reticulum. A membrane-permeable allosteric agonist of the LHR has been shown to serve as a pharmacological chaperone for misfolded and intracellularly retained LHRs by promoting their cell surface expression. Wild-type LHR and FSHR each form homodimers and heterodimers while in the ER. Therefore, when wild-type receptor is co-expressed with a misfolded mutant, the misfolded receptor dimerizes with immature wild-type receptor in the ER, causing a dominant-negative effect on cell surface expression of the mature wild-type receptor. Notably, the propensity for homodimerization is not affected by the activation status of the receptor. However, within a receptor dimer, the activity of one protomer may allosterically regulate the other protomer. Therefore, the dimerization of the gonadotropin receptors appears to be an obligate process that is part of the normal itinerary for trafficking to the cell surface and, once there, the dimerized receptors allow for additional modulations of cell signaling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abell AN, McCormick DJ, Segaloff DL (1998) Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs. Mol Endocrinol 12(12):1857–1869
Angers S, Salahpour A, Bouvier M (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42:409–435
Apaja PM, Harju KT, Aatsinki JT, Petaja-Repo UE, Rajaniemi HJ (2004) Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. J Biol Chem 279(3):1899–1906. doi:10.1074/jbc.M311395200, pii:M311395200
Ascoli M, Fanelli F, Segaloff DL (2002) The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 23(2):141–174
Bai M (2004) Dimerization of G-protein-coupled receptors: roles in signal transduction. Cell Signal 16(2):175–186, pii:S0898656803001281
Banerjee P, Fazleabas AT (2011) Extragonadal actions of chorionic gonadotropin. Rev Endocr Metab Disord. doi:10.1007/s11154-011-9193-1
Berndt S, Perrier d’Hauterive S, Blacher S, Pequeux C, Lorquet S, Munaut C, Applanat M, Herve MA, Lamande N, Corvol P, van den Brule F, Frankenne F, Poutanen M, Huhtaniemi I, Geenen V, Noel A, Foidart JM (2006) Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J 20(14):2630–2632. doi:10.1096/fj.06-5885fje, pii:fj.06-5885fje
Blair HC, Zaidi M (2006) Osteoclastic differentiation and function regulated by old and new pathways. Rev Endocr Metab Disord 7(1–2):23–32. doi:10.1007/s11154-006-9010-4
Braun T, Schofield PR, Sprengel R (1991) Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 10:1885–1890
Cameo P, Szmidt M, Strakova Z, Mavrogianis P, Sharpe-Timms KL, Fazleabas AT (2006) Decidualization regulates the expression of the endometrial chorionic gonadotropin receptor in the primate. Biol Reprod 75(5):681–689. doi:10.1095/biolreprod.106.051805, pii:biolreprod.106.051805
Crine P, Aubry M, Potier M (1984) Incorporation of radiolabeled amino acids into protein subunits of the rat Leydig cell gonadotropin receptor. Ann N Y Acad Sci 438:224–237
Davis D, Liu X, Segaloff DL (1995) Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol 9:159–170
Davis DP, Rozell TG, Liu X, Segaloff DL (1997) The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not essential for correct folding, cell surface expression, hormone binding, or signal transduction. Mol Endocrinol 11:550–562
De Leener A, Montanelli L, Van Durme J, Chae H, Smits G, Vassart G, Costagliola S (2006) Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab 91(2):555–562
Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761–764
Donadeu FX, Ascoli M (2005) The differential effects of the gonadotropin receptors on aromatase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade. Endocrinology 146(9):3907–3916. doi:10.1210/en.2005-0403, pii:en.2005-0403
Dos Santos E, Dieudonne MN, Leneveu MC, Pecquery R, Serazin V, Giudicelli Y (2007) In vitro effects of chorionic gonadotropin hormone on human adipose development. J Endocrinol 194(2):313–325. doi:10.1677/JOE-06-0101, pii:194/2/313
Ellgaard L, Helenius A (2003) Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4(3):181–191
Escamilla-Hernandez R, Little-Ihrig L, Orwig KE, Yue J, Chandran U, Zeleznik AJ (2008) Constitutively active protein kinase a qualitatively mimics the effects of follicle-stimulating hormone on granulosa cell differentiation. Mol Endocrinol 22(8):1842–1852. doi:10.1210/me.2008-0103
Fabritz J, Ryan S, Ascoli M (1998) Transfected cells express mostly the intracellular precursor of the lutropin/choriogonadotropin receptor but this precursor binds choriogonadotropin with high affinity. Biochemistry 37:664–672
Fan QR, Hendrickson WA (2005) Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433(7023):269–277
Fan QR, Hendrickson WA (2007) Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor. Mol Cell Endocrinol 260–262:73–82. doi:10.1016/j.mce.2005.12.055, pii:S0303-7207(06)00426-6
Fanelli F, Verhoef-Post M, Timmerman M, Zeilemaker A, Martens JW, Themmen AP (2004) Insight into mutation-induced activation of the luteinizing hormone receptor: molecular simulations predict the functional behavior of engineered mutants at M398. Mol Endocrinol 18(6):1499–1508
Frigerio L, Lord JM (2000) Glycoprotein degradation: do sugars hold the key? Curr Biol 10(18):R674–R677
Guan R, Feng X, Wu X, Zhang M, Zhang X, Hebert TE, Segaloff DL (2009) Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization. J Biol Chem 284(12):7483–7494. doi:10.1074/jbc.M809150200, pii:M809150200
Guan R, Wu X, Feng X, Zhang M, Hebert TE, Segaloff DL (2010) Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors. Cell Signal 22(2):247–256. doi:10.1016/j.cellsig.2009.09.023, pii:S0898-6568(09)00273-3
Guo W, Urizar E, Kralikova M, Mobarec JC, Shi L, Filizola M, Javitch JA (2008) Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J 27(17):2293–2304. doi:10.1038/emboj.2008.153, pii:emboj2008153
Han Y, Moreira IS, Urizar E, Weinstein H, Javitch JA (2009) Allosteric communication between protomers of dopamine class a GPCR dimers modulates activation. Nat Chem Biol. doi:10.1038/nchembio.199, pii:nchembio.199
Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475(7356):324–332. doi:10.1038/nature10317
Hebert TE, Gales C, Rebois RV (2006) Detecting and imaging protein-protein interactions during G protein-mediated signal transduction in vivo and in situ by using fluorescence-based techniques. Cell Biochem Biophys 45(1):85–109. doi:10.1385/CBB:45:1:85, pii:CBB:45:1:85
Hegde RS, Ploegh HL (2010) Quality and quantity control at the endoplasmic reticulum. Curr Opin Cell Biol 22(4):437–446. doi:10.1016/j.ceb.2010.05.005
Herrick-Davis K, Weaver BA, Grinde E, Mazurkiewicz JE (2006) Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer. J Biol Chem 281(37):27109–27116. doi:10.1074/jbc.M604390200, pii:M604390200
Hipkin RW, Sanchez-Yague J, Ascoli M (1992) Identification and characterization of an LH/CG receptor precursor in a human kidney cell line stably transfected with the rat luteal LH/CG receptor cDNA. Mol Endocrinol 6:2210–2218
Hirakawa T, Ascoli M (2003) A constitutively active somatic mutation of the human lutropin receptor found in Leydig cell tumors activates the same families of G proteins as germ line mutations associated with Leydig cell hyperplasia. Endocrinology 144(9):3872–3878
Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, van Duin M, Hsueh AJ (2000) The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol 14:1257–1271
Hunzicker-Dunn M, Barisas G, Song J, Roess DA (2003) Membrane organization of luteinizing hormone receptors differs between actively signaling and desensitized receptors. J Biol Chem 278(44):42744–42749
Issafras H, Angers S, Bulenger S, Blanpain C, Parmentier M, Labbe-Jullie C, Bouvier M, Marullo S (2002) Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 277(38):34666–34673. doi:10.1074/jbc.M202386200, pii:M202386200
Janovick JA, Maya-Nunez G, Ulloa-Aguirre A, Huhtaniemi IT, Dias JA, Verbost P, Conn PM (2009a) Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine. Mol Cell Endocrinol 298(1–2):84–88. doi:10.1016/j.mce.2008.09.015, pii:S0303-7207(08)00412-7
Janovick JA, Patny A, Mosley R, Goulet MT, Altman MD, Rush TS 3rd, Cornea A, Conn PM (2009b) Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor. Mol Endocrinol 23(2):157–168. doi:10.1210/me.2008-0384, pii:me.2008-0384
Jaquette J, Segaloff DL (1997) Temperature sensitivity of some mutants of the lutropin/choriogonadotropin receptor. Endocrinology 138:85–91
Jeoung M, Lee C, Ji I, Ji TH (2007) Trans-activation, cis-activation and signal selection of gonadotropin receptors. Mol Cell Endocrinol 260–262:137–143. doi:10.1016/j.mce.2005.09.015, pii:S0303-7207(06)00448-5
Ji I, Lee CW, Song YS, Conn PM, Ji TH (2002) Cis- and trans-activation of hormone receptors: the LH receptor. Mol Endocrinol 16(6):1299–1308
Kusuda S, Dufau ML (1988) Characterization of ovarian gonadotropin receptor. J Biol Chem 263:3046–3049
Lai TH, Lin YF, Wu FC, Tsai YH (2008) Follicle-stimulating hormone-induced galphah/phospholipase C-delta1 signaling mediating a noncapacitative Ca2+ influx through T-type Ca2+ channels in rat sertoli cells. Endocrinology 149(3):1031–1037. doi:10.1210/en.2007-1244
Latronico A, Segaloff D (1999) Naturally occurring mutations of the luteinizing hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet 65:949–958
Lederkremer GZ (2009) Glycoprotein folding, quality control and ER-associated degradation. Curr Opin Struct Biol 19(5):515–523. doi:10.1016/j.sbi.2009.06.004
Lee C, Ji I, Ryu K, Song Y, Conn PM, Ji TH (2002) Two defective heterozygous luteinizing hormone receptors can rescue hormone action. J Biol Chem 277(18):15795–15800. doi:10.1074/jbc.M111818200, pii:M111818200
Lei Y, Hagen GM, Smith SM, Liu J, Barisas G, Roess DA (2007) Constitutively-active human LH receptors are self-associated and located in rafts. Mol Cell Endocrinol 260–262:65–72. doi:10.1016/j.mce.2005.11.046, pii:S0303-7207(06)00425-4
McFarland KC, Sprengel R, Phillips HS, Kohler M, Rosemblit N, Nikolics K, Segaloff DL, Seeburg PH (1989) Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 245:494–499
McMillin SM, Heusel M, Liu T, Costanzi S, Wess J (2011) Structural basis of M3 muscarinic receptor dimer/oligomer formation. J Biol Chem 286(32):28584–28598. doi:10.1074/jbc.M111.259788
Mercier J-F, Salahpour A, Angers S, Breit A, Bouvier M (2002) Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277(47):44925–44931
Minegishi T, Nakamura K, Yamashita S, Omori Y (2007) The effect of splice variant of the human luteinizing hormone (LH) receptor on the expression of gonadotropin receptor. Mol Cell Endocrinol 260–262:117–125. doi:10.1016/j.mce.2005.11.051, pii:S0303-7207(06)00452-7
Mizrachi D, Segaloff DL (2004) Intracellularly located misfolded glycoprotein hormone receptors associate with different chaperone proteins than their cognate wild-type receptors. Mol Endocrinol 18(7):1768–1777
Montanelli L, Delbaere A, Di Carlo C, Nappi C, Smits G, Vassart G, Costagliola S (2004a) A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 89(4):1255–1258
Montanelli L, Van Durme JJ, Smits G, Bonomi M, Rodien P, Devor EJ, Moffat-Wilson K, Pardo L, Vassart G, Costagliola S (2004b) Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor. Mol Endocrinol 18(8):2061–2073
Nakamura K, Yamashita S, Omori Y, Minegishi T (2004) A splice variant of the human luteinizing hormone (LH) receptor modulates the expression of wild-type human LH receptor. Mol Endocrinol 18(6):1461–1470. doi:10.1210/me.2003-0489, pii:me.2003-0489
Newton CL, Whay AM, McArdle CA, Zhang M, van Koppen CJ, van de Lagemaat R, Segaloff DL, Millar RP (2011) Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist. Proc Natl Acad Sci U S A 108(17):7172–7176. doi:10.1073/pnas.1015723108
Overton MC, Blumer KJ (2002) The extracellular N-terminal domain and transmembrane domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor. J Biol Chem 277(44):41463–41472
Piersma D, Verhoef-Post M, Berns EM, Themmen AP (2007) LH receptor gene mutations and polymorphisms: an overview. Mol Cell Endocrinol 260–262:282–286. doi:10.1016/j.mce.2005.11.048, pii:S0303-7207(06)00434-5
Quintana J, Hipkin RW, Ascoli M (1993) A polyclonal antibody to a synthetic peptide derived from the rat follicle-stimulating hormone receptor reveals the recombinant receptor as a 74-kilodalton protein. Endocrinology 133:2098–2104
Radu A, Pichon C, Camparo P, Antoine M, Allory Y, Couvelard A, Fromont G, Hai MT, Ghinea N (2010) Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med 363(17):1621–1630. doi:10.1056/NEJMoa1001283
Reisinger K, Baal N, McKinnon T, Munstedt K, Zygmunt M (2007) The gonadotropins: tissue-specific angiogenic factors? Mol Cell Endocrinol 269(1–2):65–80. doi:10.1016/j.mce.2006.11.015, pii:S0303-7207(07)00050-0
Rivero-Muller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH, Huhtaniemi I (2010) Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci U S A 107(5):2319–2324. doi:10.1073/pnas.0906695106, pii:0906695106
Roess DA, Smith SM (2003) Self-association and raft localization of functional luteinizing hormone receptors. Biol Reprod 69(6):1765–1770. doi:10.1095/biolreprod.103.018846, pii:biolreprod.103.018846
Roess DA, Horvat RD, Munnelly H, Barisas BG (2000) Luteinizing hormone receptors are self-associated in the plasma membrane. Endocrinology 141(12):4518–4523
Rozell TG, Wang H, Liu X, Segaloff DL (1995) Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not the lutropin/choriogonadotropin receptor. Mol Endocrinol 9:1727–1736
Salahpour A, Angers S, Mercier JF, Lagace M, Marullo S, Bouvier M (2004) Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279(32):33390–33397
Segaloff DL (2009) Diseases associated with mutations of the human lutropin receptor. Prog Mol Biol Transl Sci 89C:97–114. doi:10.1016/S1877-1173(09)89004-2, pii:S1877-1173(09)89004-2
Segaloff DL, Ascoli M (1993) The lutropin/choriogonadotropin (LH/CG) receptor-4 years later. Endocr Rev 14:324–347
Simoni M, Gromoll J, Nieschlag E (1997) The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739–773
Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S (2003) Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 349(8):760–766
Sprengel R, Braun T, Nikolics K, Segaloff DL, Seeburg PH (1990) The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol 4:525–530
Srisuparp S, Strakova Z, Brudney A, Mukherjee S, Reierstad S, Hunzicker-Dunn M, Fazleabas AT (2003) Signal transduction pathways activated by chorionic gonadotropin in the primate endometrial epithelial cells. Biol Reprod 68(2):457–464
Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M (2006) FSH directly regulates bone mass. Cell 125(2):247–260. doi:10.1016/j.cell.2006.01.051
Tao YX (2006) Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol Ther 111(3):949–973. doi:10.1016/j.pharmthera.2006.02.008, pii:S0163-7258(06)00028-3
Tao YX, Johnson NB, Segaloff DL (2004) Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem 279(7):5904–5914
Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, Jockers R, Barberis C, Bouvier M (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 17(4):677–691
Thomas D, Rozell TG, Liu X, Segaloff DL (1996) Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repaets 1–6 are involved in hormone binding. Mol Endocrinol 10:760–768
Thomas RM, Nechamen CA, Mazurkiewicz JE, Muda M, Palmer S, Dias JA (2007) Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing. Endocrinology 148(5):1987–1995. doi:10.1210/en.2006-1672, pii:en.2006-1672
Trombetta ES, Helenius A (1998) Lectins as chaperones in glycoprotein folding. Curr Opin Struct Biol 8(5):587–592
Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G, Costagliola S (2005) Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 24(11):1954–1964
Vasseur C, Rodien P, Beau I, Desroches A, Gerard C, de Poncheville L, Chaplot S, Savagner F, Croue A, Mathieu E, Lahlou N, Descamps P, Misrahi M (2003) A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 349(8):753–759
Vassilakos A, Michalak M, Lehrman MA, Williams DB (1998) Oligosaccharide binding characteristics of the molecular chaperones calnexin and calreticulin. Biochemistry 37(10):3480–3490
Xie YB, Wang H, Segaloff DL (1990) Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. J Biol Chem 265:21411–21414
Zhang M, Mizrachi D, Fanelli F, Segaloff DL (2005) The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the naturally occurring L457R mutation of the human lutropin receptor. J Biol Chem 280(28):26169–26176
Zhang M, Tao YX, Ryan GL, Feng X, Fanelli F, Segaloff DL (2007) Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J Biol Chem 282:25527–25539
Zhang M, Feng X, Guan R, Hebert TE, Segaloff DL (2009) A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerization. Cell Signal 21(11):1663–1671. doi:10.1016/j.cellsig.2009.07.003, pii:S0898-6568(09)00210-1
Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, Lang U, Preissner KT (2002) Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 87(11):5290–5296
Acknowledgements
Studies from the author’s laboratory discussed herein were supported by NIH grants HD022196 and DK068614.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Segaloff, D.L. (2012). Regulatory Processes Governing the Cell Surface Expression of LH and FSH Receptors. In: Dupré, D., Hébert, T., Jockers, R. (eds) GPCR Signalling Complexes – Synthesis, Assembly, Trafficking and Specificity. Subcellular Biochemistry, vol 63. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4765-4_7
Download citation
DOI: https://doi.org/10.1007/978-94-007-4765-4_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4764-7
Online ISBN: 978-94-007-4765-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)